Written Question·Department of Health and Social Care·UIN HL16619
Tabled: 21 April 2026
Question
To ask His Majesty's Government what assessment they have made of clinical trials of donanemab and lecanemab for treating Alzheimer's conditions; and whether they plan to provide those drugs through the NHS.